2017 Vol.29(6)
Display Mode： |
2017, 29(6): 471-476.
doi: 10.21147/j.issn.1000-9604.2017.06.01
Abstract
FullText HTML
PDF 331KB
Abstract:
ObjectiveEstimating the incidence and mortality rate of cervical cancer became necessary to establish prevention measures and healthy policies. The aim of this study was to estimate the updated incidence and mortality rate of cervical cancer in 2013 ...
2017, 29(6): 477-486.
doi: 10.21147/j.issn.1000-9604.2017.06.02
Abstract:
ObjectiveTo analyze the trends of incidence rate and age at diagnosis for cervical cancer incidence in China using population-based cancer registration data from 2000 to 2014. MethodsData were from National Central Cancer Registry of China. Crude inci...
2017, 29(6): 487-495.
doi: 10.21147/j.issn.1000-9604.2017.06.03
Abstract:
ObjectiveThis study was designed to explore the time trends in geographical variations of cervical cancer mortality in mainland China over the period 1973 to 2013, to provide subnational spatio-temporal patterns for targeted promotion of human papill...
2017, 29(6): 496-509.
doi: 10.21147/j.issn.1000-9604.2017.06.04
Abstract:
ObjectiveCareHPV is a human papillomavirus (HPV) DNA test for low-resource settings (LRS). This study assesses optimum triage strategies for careHPV-positive women in LRS. MethodsA total of 2,530 Chinese women were concurrently screened for cervical c...
2017, 29(6): 510-520.
doi: 10.21147/j.issn.1000-9604.2017.06.05
Abstract:
ObjectiveThe aim of this study was to investigate the prognostic factors and to evaluate the impact of adjuvant therapy on clinical outcome for early-stage cervical cancer. MethodsThe clinical-pathological data of all 1,335 patients with the Internati...
2017, 29(6): 521-532.
doi: 10.21147/j.issn.1000-9604.2017.06.06
Abstract:
ObjectivePrimary uterine leiomyosarcomas (ULMS) are rare, and the optimal treatment is controversial. We aimed to assess the outcome and prognostic factors in a multicenter population of women treated for primary ULMS. MethodsWe retrospectively collec...
2017, 29(6): 543-552.
doi: 10.21147/j.issn.1000-9604.2017.06.09
Abstract:
ObjectiveData on the clinical activity of epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKIs) in patients with non-small-cell lung cancer (NSCLC) and uncommon EGFR mutations remain insufficient. This study aimed to investigate t...
2017, 29(6): 553-560.
doi: 10.21147/j.issn.1000-9604.2017.06.10
Abstract:
Objective Although superior clinical benefits of epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKIs) in the treatment of advanced non-small-cell lung cancer (NSCLC) had been reported, the survival difference between exon 19 dele...
2017, 29(6): 561-571.
doi: 10.21147/j.issn.1000-9604.2017.06.11
Abstract:
ObjectiveHigh-dose chemotherapy (HDC) followed by autologous stem cell transplantation (ASCT) is the standard of care in the upfront or relapsed/refractory setting in some patients with non-Hodgkin lymphoma (NHL). However, a proportion of patients do...
2017, 29(6): 572-580.
doi: 10.21147/j.issn.1000-9604.2017.06.12
Abstract:
ObjectiveAs an important regulator of embryonic morphogenesis, homeodomain-containing gene 10 (HOXC10) has been found to promote progression of human cancers and its expression indicates poor survival outcome. However, very few studies are available ...
2017, 29(6): 581-586.
doi: 10.21147/j.issn.1000-9604.2017.06.13
Abstract:
ObjectiveTo analyze the angiography appearance of liver metastases from gastroenteropancreatic neuroendocrine tumors (GEP-NETs), and evaluate the clinical efficacy and prognostic factors of interventional treatment for hepatic metastases. MethodsFifty...
2017, 29(6): 533-534.
doi: 10.21147/j.issn.1000-9604.2017.06.07
Abstract:
2017, 29(6): 587-588.
doi: 10.21147/j.issn.1000-9604.2017.06.14
Abstract:
2017, 29(6): 535-542.
doi: 10.21147/j.issn.1000-9604.2017.06.08
Abstract:
Leptomeningeal metastasis is an uncommon but serious complication in patients with advanced cancers. Leptomeningeal metastasis is diagnosed in approximately 5% of the patients, most commonly among patients with cancers of breast and lung, melanoma, a...
Leptomeningeal metastasis is an uncommon but serious complication in patients with advanced cancers. Leptomeningeal metastasis is diagnosed in approximately 5% of the patients, most commonly among patients with cancers of breast and lung, melanoma, a...
